Alexander Arrow

Alexander K.
Arrow is the founder of Virchow Medical, Inc., founded in 2023, serving as Chief Executive Officer & Director.
Dr. Arrow was the founder of Rindex Medical, Inc., founded in 2011, serving as Chief Executive Officer & Director.
Dr. Arrow is currently Chief Executive Officer & Director at Lab Nine, Inc. Dr. Arrow is currently Director & Operations Consultant at Zelegent, Inc. Dr. Arrow is currently Director at Insightful Instruments, Inc. since 2022.
Dr. Arrow is currently President & Chief Financial Officer at Strateos, Inc. since 2023.
Former positions include Chief Executive Officer & Director at Zelegent, Inc. from 2015 to 2020; President, COO, Director & Chief Medical Officer at BIOLASE, Inc. in 2014; Chief Financial Officer & Medical Director at Arstasis, Inc. from 2007 to 2012; Chief Operating Officer & Director at Neumedicines, Inc. in 2015; Independent Director at Medcura, Inc.; Director at Biolx, Inc. from 2010 to 2014; Independent Director at 8i Enterprises Acquisition Corp.
from 2019 to 2020; Director at Paragonix, Inc.; Independent Director at 8i Acquisition 2 Corp.; Chief Financial Officer & Director at Carlsmed, Inc. from 2019 to 2022; Director at Paragonix Technologies, Inc. from 2020 to 2023; Principal at Wedbush Securities, Inc. in 1999; Head-Medical Technology Research at Lazard, Inc.; Chief Financial Officer at Protagenic Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at PLX Systems, Inc. from 1999 to 2001; Senior Vice President at FM Partners Holdings LLC; Principal at Ladenburg Thalmann & Co., Inc. in 2002; Chief Financial Officer at Atrinsic, Inc.; Chief Strategic Officer at Circuit Therapeutics, Inc. in 2013; Chief Financial Officer at Patent & License Exchange, Inc. from 1999 to 2001.
Education includes an undergraduate degree from Cornell University conferred in 1992 and a doctorate from Harvard Medical School conferred in 1996.